Blue Earth Therapeutics

Developer of targeted radiopharmaceuticals to treat patients with cancer

placeOxford, England, United Kingdom calendar_todayFounded 2021 language blueearththerapeutics.com

Registered entities

Social engagement

Social engagement: 3.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Soleus Capital, Sands Capital.

Investor typeCountShare
Private equity360%
Other / undisclosed240%

Recent activity

2 Jul 2026
Recognition
22 Jun 2026
Event
Targeted Radiotherapeutics MicroSummit
18 Jun 2026
Event
SNMMI2026
Coming soon